Study published in Journal of Surgical Research evaluates optimal deployment pressure for F.O.A.M.™ device

Critical Innovations is pleased to announce the publication of a new preclinical study in the Journal of Surgical Research evaluating the company’s thermoreversible intra-abdominal foam, Fast Onset Abdominal Management™ (F.O.A.M.™), for treating noncompressible torso hemorrhage (NCTH). F.O.A.M.™ deploys a rapidly expanding thermoreversible foaming agent from a prefilled pressurized canister via an autostopping needle inserted into the peritoneal cavity. In a porcine model of NCTH, this study investigated the optimal intra-abdominal deployment pressure for the foaming agent. At the final analysis, two pressures (70 mmHg and 80 mmHg) remained in the 95% credible interval. These findings support F.O.A.M.'s potential as a field-deployable solution for managing NCTH in both military and civilian trauma settings. Read the full article here.

Swine survival time. Left: swine survival time by pressure target. Right: standardized swine survival time by pressure target (percentage).